Diagnosis and treatment of cystic lung disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cystic lung disease (CLD) is a group of lung disorders characterized by the presence of multiple cysts, defined as air-filled lucencies or low-attenuating areas, bordered by a thin wall (usually < 2 mm). The recognition of CLDs has increased with the widespread use of computed tomography. This article addresses the mechanisms of cyst formation and the diagnostic approaches to CLDs. A number of assessment methods that can be used to confirm CLDs are discussed, including high-resolution computed tomography, pathologic approaches, and genetic/ serologic markers, together with treatment modalities, including new therapeutic drugs currently being evaluated. The CLDs covered by this review are lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dube syndrome, lymphocytic interstitial pneumonia/follicular bronchiolitis, and amyloidosis.
Abstract
Cystic lung disease (CLD) is a group of lung disorders characterized by the presence of multiple cysts, defined as air-filled lucencies or low-attenuating areas, bordered by a thin wall (usually < 2 mm). The recognition of CLDs has increased with the widespread use of computed tomography. This article addresses the mechanisms of cyst formation and the diagnostic approaches to CLDs. A number of assessment methods that can be used to confirm CLDs are discussed, including high-resolution computed tomography, pathologic approaches, and genetic/ serologic markers, together with treatment modalities, including new therapeutic drugs currently being evaluated. The CLDs covered by this review are lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dube syndrome, lymphocytic interstitial pneumonia/follicular bronchiolitis, and amyloidosis.
참고문헌 (57)
- Hansell DM, "Fleischner Society: glossary of terms for thoracic imaging", Radiology, 246, pp.697~722 (2008)
- 박혜윤, "A Nationwide Survey of Lymphangioleiomyomatosis in Korea: Recent Increase in Newly Diagnosed Patients", Journal of Korean Medical Science, 25(8), pp.1182~1186 (2010), 대한의학회
- Copley SJ, "Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old", Radiology, 251, pp.566~573 (2009)
- Gupta N, "Diffuse cystic lung disease: part I", Am J Respir Crit Care Med, 191, pp.1354~1366 (2015)
- 권용수, "Mycobacterium avium lung disease combined with a bronchogenic cyst in an immunocompetent young adult", The Korean Journal of Internal Medicine, 28(1), pp.94~97 (2013), 대한내과학회[DOI]
- Dines DE., "Diagnostic significance of pneumatocele of the lung", AMA, 204, pp.1169~1172 (1968)
- Kikuchi E, "Epithelioid sarcoma presenting as pulmonary cysts with cancer antigen 125 expression", Respirology, 11, pp.826~829 (2006)
- Seaman DM, "Diffuse cystic lung disease at high-resolution CT", AJR Am J Roentgenol, 196, pp.1305~1311 (2011)
- Clarke BE., "Cystic lung disease", J Clin Pathol, 66, pp.904~908 (2013)
- So-Yeon Jeon, "Epithelioid sarcoma with spontaneous pneumothorax and massive pleural effusion", The Korean Journal of Internal Medicine, 31(1), pp.191~193 (2016), 대한내과학회[DOI]
- Lee KN, "Cystic lung disease: a comparison of cystic size, as seen on expiratory and inspiratory HRCT scans", Korean J Radiol, 1, pp.84~90 (2000)
- Ohdama S, "Primary diffuse alveolar septal amyloidosis with multiple cysts and calcification", Eur Respir J, 9, pp.1569~1571 (1996)
- Masuzawa M, "Association of D2-40 and MMP-1 expression with cyst formation in lung metastatic lesions of cutaneous angiosarcoma on the scalp: immunohistochemical analysis of 23 autopsy cases", Hum Pathol, 44, pp.2751~2759 (2013)
- Goncharova EA, "Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)", Sci Transl Med, 4, pp.154ra134~ (2012)
- Kumasaka T, "Characterization of pulmonary cysts in Birt-Hogg-Dube syndrome: histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients", Histopathology, 65, pp.100~110 (2014)
- Goncharova EA, "Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK", Cell Rep, 7, pp.412~423 (2014)
- Trotman-Dickenson B., "Cystic lung disease: achieving a radiologic diagnosis", Eur J Radiol, 83, pp.39~46 (2014)
- Ferreira Francisco FA, "Multiple cystic lung disease", Eur Respir Rev, 24, pp.552~564 (2015)
- Gupta N, "Diffuse cystic lung disease: part II", Am J Respir Crit Care Med, 192, pp.17~29 (2015)
- Harari S, "The changing face of a rare disease: lymphangioleiomyomatosis", Eur Respir J, 46, pp.1471~1485 (2015)
- Badalian-Very G, "Recurrent BRAF mutations in Langerhans cell histiocytosis", Blood, 116, pp.1919~1923 (2010)
- Johnson SR, "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis", Eur Respir J, 35, pp.14~26 (2010)
- Meraj R, "Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment", Semin Respir Crit Care Med, 33, pp.486~497 (2012)
- Samueli S, "Tuberous sclerosis complex: new criteria for diagnostic work-up and management", Wien Klin Wochenschr, 127, pp.619~630 (2015)
- Tobino K, "Computed tomographic features of lymphangioleiomyomatosis: evaluation in 138 patients", Eur J Radiol, 84, pp.534~541 (2015)
- Hayashi T, "Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis:a clinicopathologic study of 10patients", Am J Surg Pathol, 35, pp.1776~1785 (2011)
- Glasgow CG, "Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement", Chest, 135, pp.1293~1300 (2009)
- Young LR, "Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases", Chest, 138, pp.674~681 (2010)
- Davies DM, "Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial", Clin Cancer Res, 17, pp.4071~4081 (2011)
- McCormack FX, "Efficacy and safety of sirolimus in lymphangioleiomyomatosis", N Engl J Med, 364, pp.1595~1606 (2011)
- Taveira-DaSilva AM, "Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus", Ann Intern Med, 154, pp.797~805 (2011)
- Bissler JJ, "Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial", Lancet, 381, pp.817~824 (2013)
- Goldberg HJ, "Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study", Eur Respir J, 46, pp.783~794 (2015)
- Hammes SR, "Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM)", Horm Cancer, 4, pp.70~77 (2013)
- Moir LM., "Lymphangioleiomyomatosis: current understanding and potential treatments", Pharmacol Ther, 158, pp.114~124 (2016)
- Jawad H, "Cystic interstitial lung diseases: recognizing the common and uncommon entities", Curr Probl Diagn Radiol, 43, pp.115~127 (2014)
- Bernstrand C, "Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood", Acta Paediatr, 89, pp.1389~1392 (2000)
- Casolaro MA, "Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking", Am Rev Respir Dis, 137, pp.406~411 (1988)
- Yousem SA, "Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality", Am J Surg Pathol, 25, pp.630~636 (2001)
- Suri HS, "Pulmonary langerhans cell histiocytosis", Orphanet J Rare Dis, 7, pp.16~ (2012)
- Sahm F, "BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis", Blood, 120, pp.e28~e34 (2012)
- Tazi A, "Serial computed tomography and lung function testing in pulmonary Langerhans’cell histiocytosis", Eur Respir J, 40, pp.905~912 (2012)
- Brauner MW, "Pulmonary histiocytosis X: evaluation with high-resolution CT", Radiology, 172, pp.255~258 (1989)
- Lorillon G, "Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis", Am J Respir Crit Care Med, 186, pp.930~932 (2012)
- Hyman DM, "Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations", N Engl J Med, 373, pp.726~736 (2015)
- Le Pavec J, "Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension:clinical characteristics and impact of pulmonary arterial hypertension therapies", Chest, 142, pp.1150~1157 (2012)
- Gupta N, "Pulmonary manifestations of Birt-Hogg-Dube syndrome", Fam Cancer, 12, pp.387~396 (2013)
- Agarwal PP, "Thoracic CT findings in Birt-Hogg-Dube syndrome", AJR Am J Roentgenol, 196, pp.349~352 (2011)
- 서명숙, "낭종성 폐병변으로 내원하여 진단된 Birt-Hogg-Dubé 증후군 2예", 대한내과학회지, 87(4), pp.477~483 (2014), 대한내과학회[DOI]
- Dal Sasso AA, "Birt-Hogg-Dube syndrome: state-of-the-art review with emphasis on pulmonary involvement", Respir Med, 109, pp.289~296 (2015)
- Stamatakis L, "Diagnosis and management of BHD-associated kidney cancer", Fam Cancer, 12, pp.397~402 (2013)
- Tian X, "Lymphocytic interstitial pneumonia and other benign lymphoid disorders", Semin Respir Crit Care Med, 33, pp.450~461 (2012)
- Carrillo J, "Lymphoproliferative lung disorders: a radiologic-pathologic overview. Part I:reactive disorders", Semin Ultrasound CT MR, 34, pp.525~534 (2013)
- Richards JC, "Cystic and nodular lung disease", Clin Chest Med, 36, pp.299~312 (2015)
- Cordier JF., "Pulmonary amyloidosis in hematological disorders", Semin Respir Crit Care Med, 26, pp.502~513 (2005)
- Rajagopala S, "Pulmonary amyloidosis in Sjogren’s syndrome: a case report and systematic review of the literature", Respirology, 15, pp.860~866 (2010)
- Zamora AC, "Amyloid-associated cystic lung disease", Chest, 149, pp.1223~1233 (2016)
